I work at Perrigo ( A many Pfizer) And I don't see any reason they couldn't fix this with proper warning labels. The problem I see is the bad publicity O has gotten and rather Dialysis centers will be willing to by and administrate it after all of this. They have other options that may or may not be safer but all that matters is how O and the alternative options are perceived in the eyes of the public. That is what creates the value. Stock in a company that makes nothing but placebos could be worth a ton if there people out there spending their money on it.